Depressive Disorders - Bangladesh

Revenue in the Depressive Disorders market is projected to reach US$85.57m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.74%, resulting in a market volume of US$93.30m by 2029.
In global comparison, most revenue will be generated United States (US$6.26bn in 2024).
In relation to total population figures, per person revenues of US$8.08 are generated in 2024.

Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.

The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.

Antidepressant drugs
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin norepinephrine reuptake inhibitor (SNRIs)
Serotonin modulators
Tricyclic and tetracyclic antidepressants

Psychotherapy
Mood stabilizers
Anti-anxiety and stimulant medications
Behavioral therapy

The Depressive Disorders market in Bangladesh is experiencing significant growth and development due to various factors.

Customer preferences: In Bangladesh, there is a growing awareness and acceptance of mental health issues, including depressive disorders. This is leading to an increasing number of individuals seeking professional help and treatment for their mental health conditions. As a result, there is a rising demand for medications and therapies that can effectively manage and alleviate depressive symptoms.

Trends in the market: One of the key trends in the Depressive Disorders market in Bangladesh is the increasing availability and accessibility of mental health services. The government has taken steps to improve mental healthcare infrastructure and services, leading to the establishment of more mental health clinics and hospitals across the country. Additionally, there has been a growing number of private mental health practitioners and clinics offering specialized treatments for depressive disorders.Another trend in the market is the growing use of antidepressant medications. As more individuals are seeking treatment for depressive disorders, there is an increased demand for pharmaceutical products that can effectively manage the symptoms. This has led to the introduction of a wider range of antidepressant medications in the market, providing more options for patients and healthcare providers.

Local special circumstances: Bangladesh is a densely populated country with a significant proportion of its population living in rural areas. This poses unique challenges in terms of providing mental healthcare services to the entire population. However, the government has recognized this issue and has implemented various initiatives to improve access to mental health services in rural areas. This includes the training of healthcare workers in rural areas to identify and provide basic mental health support, as well as the use of telemedicine to connect patients in remote areas with mental health professionals.

Underlying macroeconomic factors: The growing Depressive Disorders market in Bangladesh can also be attributed to the country's overall economic development. As the economy continues to grow, there is an increasing middle class with higher disposable incomes. This allows individuals to afford mental health treatments and medications, driving the demand for services in the market. Additionally, the government's focus on improving healthcare infrastructure and services has contributed to the growth of the Depressive Disorders market.In conclusion, the Depressive Disorders market in Bangladesh is developing and expanding due to increasing customer preferences for mental health treatments, the availability of mental health services, the growing use of antidepressant medications, local special circumstances such as rural healthcare challenges, and underlying macroeconomic factors such as economic growth and government initiatives.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.